Effect of Low Molecular Weight Heparin on D-Dimer and PICC Tube Blockage of Malignant Cancer Patients
Abstract: Objective: To investigate the effect of low molecular weight heparin in patients with cancer D- dimer and PICC tube blockage, and anticoagulation effect of interference PICC catheter blockage. Methods: D-dimer High malignancy in patients with PICC catheter 30 patients were randomly divided into two groups, measured 15 cases (treatment group) accept change after low molecular weight heparin therapy D-dimer, while detected 15 cases (control group) D-dimer values were compared. Results: The treatment with relatively low molecular weight heparin in the treat- ment group at 2, 4 and 7 days after treatment reduced rate of 49.22%, 50.18% and 61.92%; the control group of patients after treatment 2,4 D-dimer and 7 days reduced rate of 6.00%, 22.13% and 13.57%. The rate of decline in treatment group is higher than the control group. Meanwhile, the low molecular weight heparin anticoagulant therapy group 1 case PICC catheter blockage, plugging rate of 6.67% in the control group had 10 cases of PICC catheter obstruction, plugging rate was 66.67%. Conclusion: Cancer patients hypercoagulable and coagulation disorders, the low molecular weight heparin treatment can significantly improve symptoms, reduce plasma D-dimer levels, while reducing the PICC catheter blockage, worthy of promotion and application.
文章引用: 陈雅萍 , 顾枫琳 , 华棋燕 , 董柏年 (2016) 低分子肝素钙对恶性肿瘤患者D-二聚体和PICC管堵塞的影响。 临床医学进展， 6， 128-131. doi: 10.12677/ACM.2016.63023
 王秀华, 王丽娟. 三向瓣膜式外周中心静脉导管的置管及护理[J]. 中国实用护理杂志, 2003, 19(3): 245-247.
 金莉, 刘鲁明. 血液高凝状态、血小板与恶性肿瘤及其转移的关系[J]. 实用肿瘤杂志, 2003, 18(5): 559-560.
 王建莱. 输液治疗护理实践指南与实施细则[M]. 北京: 人民军医出版社, 2009: 11-123.
 耿文英, 丁绍平, 孙荣艳, 等. 分子肝素钙在血液透析抗凝中的应用[J]. 中国全科医学, 2003, 6(10): 8731.
 王延瑞, 王振才, 李晓. 低分子肝素钙的药理特性及临床应用[J]. 临床荟萃, 2008(18): 855-856.
 陆森, 张海业, 陆粤就. 恶性肿瘤合并凝血功能障碍临床分析[J]. 中国现代医生, 2010, 48(23): 118-119.
 中华医学会重症医学分会. ICU患者深静脉血栓形成预防指南[J]. 中国实用外科杂志, 2009, 29(10): 793.